Dr. Heather Snyder is Senior Director of Neurosciences at VeraSci. She provides scientific and clinical input to the development of training materials for clinical assessments utilized in clinical trials for neurologic and psychiatric indications. Dr. Snyder and the scientific team also provide consultation regarding protocol design and outcome measures, as well as clinical development pathways. Additional responsibilities include provision of scientific input for data review and analyses, business development, and development of assessments on VeraSci’s eCOA platform, Pathway.
Before joining VeraSci, Dr. Snyder spent over 13 years in program leadership roles for neuroscience clinical development, within pharmaceutical clinical research departments. As such, she held positions within key biopharmaceutical companies, including Astra Merck Inc., Astra AB, Merck & Co., Cephalon, Inc., and Astra-Zeneca. Dr. Snyder led development programs for following neuroscience indications: Generalized Anxiety Disorder, Post-traumatic Stress Disorder, Attention Deficit Hyperactivity Disorder, Major Depressive Disorder, Multiple Sclerosis, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis.
Dr. Snyder obtained her BA in Philosophy from Georgetown University, and her PhD in Clinical Psychology, with a focus in Neuropsychology, from George Mason University. Her Post-Doctoral Fellowship work was done at the University of Pennsylvania.
Therapeutic Focus: Parkinson’s Disease, Multiple Sclerosis, Rare & Orphan Diseases